Literature DB >> 1905984

Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates.

M Denis1.   

Abstract

Murine peritoneal macrophages were isolated and their ability to restrict growth of a virulent Mycobacterium tuberculosis in response to IFN-gamma was assessed in various conditions. Doses of IFN-gamma ranging from 10 to 100 U stimulated high levels of antimycobacterial activity, as seen by inhibition of growth. Addition of catalase, superoxide dismutase, and other scavengers of reactive oxygen species before infection failed to abrogate this restriction of growth, suggestive of a lack of involvement of reactive oxygen species in this phenomenon. Addition of arginase before infection inhibited the bacteriostatic ability of IFN-gamma-pulsed macrophages as did addition of NG-monomethyl L-arginine, an inhibitor of the synthesis of inorganic nitrogen oxide. In both cases, this inhibition was reversed by adding excess L-arginine in the medium. Moreover, nitrite production in macrophages was correlated with their ability to restrict tubercle bacilli growth. These results imply that nitric oxide or another inorganic nitrogen oxide is an important effector molecule in restricting growth of M. tuberculosis in IFN-gamma-pulsed murine macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905984     DOI: 10.1016/0008-8749(91)90014-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  117 in total

1.  Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei.

Authors:  K Miyagi; K Kawakami; A Saito
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Potential role of cytokines in disseminated mycobacterial infections.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

3.  Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III).

Authors:  S J Gebran; Y Yamamoto; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide.

Authors:  J K Brieland; D G Remick; P T Freeman; M C Hurley; J C Fantone; N C Engleberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line.

Authors:  G Szalay; J Hess; S H Kaufmann
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

6.  Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages.

Authors:  T I Roach; C H Barton; D Chatterjee; F Y Liew; J M Blackwell
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

7.  Serum concentrations of nitrite in patients with HIV-1 infection.

Authors:  D Torre; G Ferrario; F Speranza; A Orani; G P Fiori; C Zeroli
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules.

Authors:  A H Fortier; T Polsinelli; S J Green; C A Nacy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis.

Authors:  P C Tucker; D E Griffin; S Choi; N Bui; S Wesselingh
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.